Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...

Desharnais was injured Thursday against the Maple Leafs, but managed to play through the injury. He has three assists, 87 hits, 83 blocked shots and 45 PIM in 51 contests with Vancouver, Pittsburgh ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

After Labor limited the scope of his venue review and ignored his recommendation for a Victoria Park stadium, former Brisbane ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA ...